PROMETHEUS LABORATORIES INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 4202
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
  
 
F02B INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL 171

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2006/0154,276 Methods of diagnosing inflammatory bowel diseaseDec 01, 05Jul 13, 06[C12Q, G01N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9127591 Engine supercharger drive deviceApr 06, 12Sep 08, 15[F02B, F02D]
7695908 Methods for predicting methotrexate polyglutamate levels using pharmacogeneticsJun 13, 05Apr 13, 10[C12Q]
7582282 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogeneticsAug 26, 04Sep 01, 09[G01N]
7563590 Methods of quantifying methotrexate metabolitesAug 30, 02Jul 21, 09[C12Q]
6921667 Methods for direct detection of individual methotrexate metabolitesMar 07, 03Jul 26, 05[G01N]
6183951 Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapyMay 12, 97Feb 06, 01[C12Q]
5932429 Methods of diagnosing clinical subtypes of crohn's diseaseApr 11, 97Aug 03, 99[G01N]
5225407 5-HT.sub.3 receptor antagonists for the treatment of autismSep 08, 92Jul 06, 93[A61K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2013/0143,215 Methods of Predicting Methotrexate Efficacy and ToxicityAbandonedDec 10, 12Jun 06, 13[C12Q]
2013/0131,072 Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using Metabolite Profiling and PharmacogeneticsAbandonedJan 25, 13May 23, 13[C12Q]
2010/0203,507 METHODS OF PREDICTING METHOTREXATE EFFICACY AND TOXICITYAbandonedAug 19, 08Aug 12, 10[C12Q]
2010/0203,508 METHODS OF PREDICTING METHOTREXATE EFFICACY AND TOXICITYAbandonedAug 19, 08Aug 12, 10[C12Q]
2010/0203,539 METHODS FOR PREDICTING METHOTREXATE POLYGLUTAMATE LEVELS USING PHARMACOGENETICSAbandonedFeb 02, 10Aug 12, 10[C12Q]
2010/0167,285 METHODS AND AGENTS FOR EVALUATING INFLAMMATORY BOWEL DISEASE, AND TARGETS FOR TREATMENTAbandonedMar 26, 08Jul 01, 10[C12Q, C12N, C07K]
2009/0197,267 METHODS FOR OPTIMIZING CLINICAL RESPONSIVENESS TO METHOTREXATE THERAPY USING METABOLITE PROFILING AND PHARMACOGENETICSAbandonedAug 13, 08Aug 06, 09[C12Q]
2009/0197,266 METHODS FOR OPTIMIZING CLINICAL RESPONSIVENESS TO METHOTREXATE THERAPY USING METABOLITE PROFILING AND PHARMACOGENETICSAbandonedAug 13, 08Aug 06, 09[C12Q]
2007/0093,497 METHOTREXATE COMPLIANCE PACKAGINGAbandonedOct 31, 06Apr 26, 07[A61K, B65D]
2006/0286,571 METHODS OF PREDICTING METHOTREXATE EFFICACY AND TOXICITYAbandonedApr 25, 06Dec 21, 06[C12Q]
2004/0176,381 Methotrexate compliance packagingAbandonedMar 06, 03Sep 09, 04[A61K, B65D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.